Skip to main content
← Project catalogue

Premium Project

End-of-Life Escalation Planning in Advanced Cancer Audit

Audit whether adults with advanced cancer have clear, person-centred escalation plans that document treatment goals, emergency care recommendations, CPR status, capacity, communication, palliative input and transfer-of-care arrangements.

PremiumNew
Explore Catalogue

Overview

This project audits whether escalation planning for adults with advanced cancer is clinically clear, person-centred, documented, reviewed and communicated across care settings. It reviews recognition of advanced disease and changing goals of care, treatment intent, oncology and specialist palliative care input, escalation limits, CPR and emergency care recommendations, potentially reversible complications, symptom and anticipatory planning, capacity and best-interests documentation, discussion with the person and those important to them, and whether plans are visible at the point of care and communicated at handover, discharge, transfer, community, hospice, care-home, ambulance and out-of-hours interfaces.

Specialties, services & categories

Clinical specialties:OncologyHaematologyPalliative CareAcute MedicineEmergency MedicineGeneral Internal MedicineRespiratory MedicineGastroenterologyHepatologyRenal MedicineCardiologyNeurology / StrokeSurgeryCritical Care / OutreachFrailty / Older People's CarePsychiatry / Liaison PsychiatryGeneral PracticeCommunity ServicesHospicesNursingAllied Health ProfessionalsPharmacy / Medicines Optimisation
Healthcare services:Clinical GovernancePatient SafetyNursing & AHPs
Categories:GovernancePatient Safety

Who should use it

  • Oncology, haematology and specialist palliative care teams, including cancer nurse specialists
  • Acute medicine, emergency department, ward and critical care outreach teams
  • GP practice, community, hospice and care-home clinical teams
  • Pharmacists where medicines and anticipatory prescribing are locally reviewed
  • QI leads, governance and patient safety teams, supervisors and educators

Objectives

  • Measure documentation of advanced cancer status, treatment intent and changing goals of care
  • Assess escalation limits, CPR and emergency care planning, and consideration of reversible complications
  • Review palliative care input, symptom control and anticipatory planning documentation
  • Test capacity, best-interests, discussion and family communication documentation
  • Measure review, visibility and transfer-of-care communication, and generate governance-ready and ARCP-ready evidence

Data collected

  • Anonymous case identifier
  • Inclusion / eligibility decision
  • Anonymised context (age band, sex/gender recorded, care setting, escalation context, optional cancer group)
  • Clinical area / location and optional specialty / service
  • Twenty-seven escalation-planning criteria (met / not met / not applicable)
  • Free-text learning points and any project custom fields

Outputs generated

  • Live dashboard
  • Audit report (Word)
  • Executive summary (Word)
  • Excel workbook
  • PowerPoint presentation
  • Conference poster
  • ARCP evidence summary

Governance notes

  • Designed to use anonymised or pseudonymised audit identifiers.
  • This tool supports, but does not replace, clinical judgement.
  • Local policy, formulary and specialist advice should be followed.
  • Organisations remain responsible for local governance arrangements.
  • This tool supports documentation and escalation-planning quality assurance only. It does not provide patient-specific oncology advice, palliative treatment advice, CPR decisions, emergency treatment recommendations, prognosis estimates, capacity decisions or best-interests decisions.
  • Prognosis thresholds, ceilings of care, critical care criteria, DNACPR decisions, ReSPECT categories, palliative referral triggers, symptom-control regimens, anticipatory medicines and transfer routes are locally configured and are not presented here as national standards.
  • Use anonymous case identifiers only — never patient-identifiable information, and never identifiable detail about family members, attorneys, deputies, carers, clinicians, care homes or hospices.

Lazomis QI supporting resources

Supporting guidance from the Lazomis QI Resource Library. Authoritative clinical standards referenced by this project remain separate.